Ken is a pharmacist and clinical epidemiologist with a particular interest in pharmacoepidemiology and pharmacoeconomics. He obtained his PhD under the supervision of Prof Danny Liew and is currently undertaking his PostDoctoral Fellowship at SPHPM. Ken’s specific expertise is in large datasets, data linkage and analyses for comparative effectiveness research and HTA. Ken’s skills include economic modelling, multiple imputation, propensity score analyses, survival analyses and time series analyses. Ken is actively involved in collaborations with industry, especially with regards to development of economic models for PBAC submissions.